All results
122 results for impact
-
A Study of ASP1002 in Adults for Treatment of Solid Tumors
ASP1002 is a potential new treatment for people with certain solid tumors. Before ASP1002 is available as a treatment, the researchers need to understand how…
- Ages
- 18 Years - N/A
- Sexes
- All
-
A2AR and breathing in ALS
The purpose of this research study is to determine the effects of a medication, istradefylline, in conjunction with breathing air with reduced oxygen for short…
- Ages
- 21 Years - 80 Years
- Sexes
- All
-
ADOPT PGx
This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and…
- Ages
- 8 Years - N/A
- Sexes
- All
-
AL002 Feasibility Study for Treatment of Alzheimer s Disease
The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB)…
- Ages
- 50 Years - 85 Years
- Sexes
- All
-
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
The APOLLO study is being done in an attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation based upon…
- Ages
- N/A - N/A
- Sexes
- All
-
ARCH II
This study is being done to learn about the interaction of alcohol consumption and HIV on brain function. The proposed study will have two broad objectives.…
- Ages
- 25 Years - 75 Years
- Sexes
- All
-
ARGX-113-2007
This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48)
The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Artisan
This study will determine the safety and effectiveness of the Artisan Aphakia Lens when used as a secondary implant to correct aphakia in adults. Not…
- Ages
- 22 Years - N/A
- Sexes
- All